Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: San Francisco CA, Vallejo CA, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
for
Advanced Solid Tumors, Metastatic Solid Tumors,
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07397338
Phase 1, Phase 2, Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: San Francisco CA, West Valley City UT, Irving TX,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
for
Congenital Adrenal Hyperplasia,
Location: San Francisco CA, Los Angeles CA, Fort Worth TX,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 1 - 17
Code: NCT07159841
Phase 2, Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT00736749
Recruiting
Active & Responsive
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
for
Healthy Participants With Lower-than-average Mental Well-being
Location: San Francisco CA
Sponsor: Robin Carhart-Harris, PhD, MA
Sex: All
Age: 21 - 70
Code: NCT06626139
Phase 2, Recruiting
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: San Francisco CA, Berkeley CA, Walnut Creek CA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase 2, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: San Francisco CA, Los Angeles CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
for
Bladder Cancer
Location: San Francisco CA, Salt Lake City UT, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07232602
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
for
Colorectal Cancer, Colorectal Cancer (CRC),
Location: San Francisco CA, Los Angeles CA, Duarte CA, Phoenix AZ,
Sponsor: Cartography Biosciences
Sex: All
Age: 18+
Code: NCT07321106
Phase 1, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: San Francisco CA, Palo Alto CA, Sacramento CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase 1, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: San Francisco CA, Oakland CA, Madera CA, Los Angeles CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Location: San Francisco CA, Orange CA, Phoenix AZ, Dallas TX,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase 2, Recruiting
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: San Francisco CA, Los Angeles CA, El Paso TX, Dallas TX,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06850038
Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: San Francisco CA, Palo Alto CA, Duarte CA, Portland OR,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors